Quad Technologies

About:

Quad Technologies is a biotechnology company that specializes in cell separation technologies.

Website: http://quadtechnologies.com/

Twitter/X: quad_tech

Top Investors: Sands Capital Ventures, Texas HALO Fund, Bantam Group, MassChallenge, IDEA: Northeastern University's Venture Accelerator

Description:

Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.

Total Funding Amount:

$3.01M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

2013-01-01

Founders:

Sean Kevlahan

Number of Employees:

11-50

Last Funding Date:

2016-10-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai